Phadia specialise in IgE testing technology. With more than 20 million people in the UK suffering from allergy, Phadia claims to be responsible for providing 90 per cent of IgE machines and consumables used in the UK, and 75 per cent of IgE testing world wide.
Athena is charged with developing and implementing an integrated programme tailored to encourage best practice in the management of patients suffering from allergic conditions. As well as providing Phadia with strategic counsel and support, the programme will feature advocacy development and both consumer and trade outreach activities.
The account will be headed up by senior account director Caroline Skirrow with support from account director Rawaa Abdalla.